Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,378 public trials 1,303 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

NCT02496897

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Pusan National University Busan Hospital Busan, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
  • Seoul National University Hospital Seoul, South Korea
View all 21 locations
View Trial Details
Completed

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)

NCT03654677

Conditions
Digestive System Diseases, Hepatitis, Hepatitis A Vaccine, +1 more
Locations
  • The Catholic University of Korea, Seoul St.Mary's Hospital Seoul, Banpo-dong, Seocho-gu, South Korea
  • The Catholic University of Korea, Incheon St.Mary's Hospital Incheon, Bupyeong-gu, South Korea
  • The Catholic University of Korea, Bucheon St.Mary's Hospital Bucheon-si, Gyeonggi-do, South Korea
  • The Catholic University of Korea,Uijeongbu St.Mary's Hospital Uijeongbu-si, Gyeonggi-do, South Korea
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

NCT05828745

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • First Hospital of Jilin University Changchun, Jilin, China
  • PCRN Trials Limited, trading as PCRN Auckland, Level 2, 2 Fred Thomas Drive, Takapuna, Auckland, 0622, New Zealand (hereinafter referred to as "Institution") Auckland, New Zealand
View Trial Details
Completed

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

NCT04585789

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • UZ Antwerpen Edegem, Belgium
  • Toronto General Hospital Toronto, Ontario, Canada
  • Hopital Beaujon Clichy, France
View Trial Details
Completed

Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis

NCT03318380

Conditions
Digestive System Diseases, Fibrosis, Liver Cirrhosis, +3 more
Locations
  • University of California San Diego San Diego, California, United States
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Albert Einstein Medical Center Philadelphia, Pennsylvania, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Delivering a Multi-disease Screening Tool to Migrant Populations

NCT05868005

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +45 more
Locations
  • Servicio Andaluz de Salud (SAS) (administration of the participant PCCs in Andalusia) Almería, Andalusia, Spain
  • Institut Català de la Salut (ICS) (administration of the participant PCCs in Catalonia) Tortosa, Catalonia, Spain
View Trial Details
Completed

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

NCT04696055

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • USC Norris Hospital and Clinics Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 39 locations
View Trial Details

Related conditions